Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Theoretical foundations of educational strategies used in e-learning environments for developing clinical reasoning in nursing students: A scoping review.

Deschênes MF, Goudreau J, Fontaine G, Charette M, Da Silva KB, Maheu-Cadotte MA, Boyer L.

Nurse Educ Pract. 2019 Nov;41:102632. doi: 10.1016/j.nepr.2019.102632. Epub 2019 Oct 1. Review.

PMID:
31634697
2.

Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial.

Schwarzschild MA, Macklin EA, Bakshi R, Battacharyya S, Logan R, Espay AJ, Hung AY, Bwala G, Goetz CG, Russell DS, Goudreau JL, Parashos SA, Saint-Hilaire MH, Rudolph A, Hare JM, Curhan GC, Ascherio A; Parkinson Study Group SURE-PD Investigators.

Neurology. 2019 Oct 1;93(14):e1328-e1338. doi: 10.1212/WNL.0000000000008194. Epub 2019 Sep 4.

PMID:
31484712
3.

Factors influencing the practice of new graduate nurses: A focused ethnography of acute care settings.

Charette M, Goudreau J, Bourbonnais A.

J Clin Nurs. 2019 Oct;28(19-20):3618-3631. doi: 10.1111/jocn.14959. Epub 2019 Jun 28.

PMID:
31190368
4.

How do new graduated nurses from a competency-based program demonstrate their competencies? A focused ethnography of acute care settings.

Charette M, Goudreau J, Bourbonnais A.

Nurse Educ Today. 2019 Aug;79:161-167. doi: 10.1016/j.nedt.2019.05.031. Epub 2019 May 22.

PMID:
31132728
5.

Critical appraisal of the recent US FDA approval for earlier DBS intervention.

Cabrera LY, Goudreau J, Sidiropoulos C.

Neurology. 2018 Jul 17;91(3):133-136. doi: 10.1212/WNL.0000000000005829. Epub 2018 Jun 13. Review.

PMID:
29898975
6.

Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease.

Fischer DL, Auinger P, Goudreau JL, Paumier KL, Cole-Strauss A, Kemp CJ, Lipton JW, Sortwell CE.

Parkinsonism Relat Disord. 2018 Aug;53:70-75. doi: 10.1016/j.parkreldis.2018.05.003. Epub 2018 May 9.

PMID:
29759928
7.

Metabolism of Dopamine in Nucleus Accumbens Astrocytes Is Preserved in Aged Mice Exposed to MPTP.

Winner BM, Zhang H, Farthing MM, Karchalla LM, Lookingland KJ, Goudreau JL.

Front Aging Neurosci. 2017 Dec 12;9:410. doi: 10.3389/fnagi.2017.00410. eCollection 2017.

8.

Psychometric analysis of the TRANSIT quality indicators for cardiovascular disease prevention in primary care.

Khanji C, Bareil C, Hudon E, Goudreau J, Duhamel F, Lussier MT, Perreault S, Lalonde G, Turcotte A, Berbiche D, Martin É, Lévesque L, Gagnon MM, Lalonde L.

Int J Qual Health Care. 2017 Dec 1;29(8):999-1005. doi: 10.1093/intqhc/mzx145.

PMID:
29190350
9.

Autonomic and electrocardiographic findings in Parkinson's disease.

Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS; NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.

Auton Neurosci. 2017 Jul;205:93-98. doi: 10.1016/j.autneu.2017.04.002. Epub 2017 Apr 14.

10.

A nursing education research framework for transformative learning and interdependence of academia and practice.

Pepin J, Goudreau J, Lavoie P, Bélisle M, Blanchet Garneau A, Boyer L, Larue C, Lechasseur K.

Nurse Educ Today. 2017 May;52:50-52. doi: 10.1016/j.nedt.2017.02.001. Epub 2017 Feb 14. No abstract available.

PMID:
28249197
11.

Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1.

Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, Leehey M, Zweig RM, Nicholas AP, Bodis-Wollner I, Willis A, Kieburtz K, Tilley BC; NINDS NET-PD Investigators.

J Parkinsons Dis. 2017;7(1):117-127. doi: 10.3233/JPD-160965.

PMID:
27911341
12.

Agir avec humanisme.

Létourneau D, Cara C, Goudreau J.

Perspect Infirm. 2016 Nov-Dec;13(5):32-34. French. No abstract available.

PMID:
29381278
13.

FosB and ΔFosB expression in brain regions containing differentially susceptible dopamine neurons following acute neurotoxicant exposure.

Patterson JR, Kim EJ, Goudreau JL, Lookingland KJ.

Brain Res. 2016 Oct 15;1649(Pt A):53-66. doi: 10.1016/j.brainres.2016.08.030. Epub 2016 Aug 24.

14.

External facilitators and interprofessional facilitation teams: a qualitative study of their roles in supporting practice change.

Lessard S, Bareil C, Lalonde L, Duhamel F, Hudon E, Goudreau J, Lévesque L.

Implement Sci. 2016 Jul 16;11:97. doi: 10.1186/s13012-016-0458-7.

15.

Choice of dopaminergic therapy among early, mild Parkinson disease subjects in North America.

Goudreau JL, Pérez A, Aminoff MJ, Boyd JT, Burau KD, Christine CW, Leehey M, Morgan JC; NET-PD Investigators.

J Neurol Sci. 2016 Jul 15;366:74-81. doi: 10.1016/j.jns.2016.04.021. Epub 2016 Apr 16.

PMID:
27288780
16.

Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors.

Simkins TJ, Fried D, Parikh K, Galligan JJ, Goudreau JL, Lookingland KJ, Kaplan BL.

J Neuroimmune Pharmacol. 2016 Dec;11(4):669-679. Epub 2016 Jun 10.

PMID:
27287619
17.

A competency-based approach to nurses' continuing education for clinical reasoning and leadership through reflective practice in a care situation.

Goudreau J, Pepin J, Larue C, Dubois S, Descôteaux R, Lavoie P, Dumont K.

Nurse Educ Pract. 2015 Nov;15(6):572-8. doi: 10.1016/j.nepr.2015.10.013. Epub 2015 Oct 29.

PMID:
26559351
18.

Facilitating Implementation of Interprofessional Collaborative Practices Into Primary Care: A Trilogy of Driving Forces.

Bareil C, Duhamel F, Lalonde L, Goudreau J, Hudon E, Lussier MT, Lévesque L, Lessard S, Turcotte A, Lalonde G.

J Healthc Manag. 2015 Jul-Aug;60(4):287-300.

PMID:
26364352
19.

Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.

Hawong HY, Patterson JR, Winner BM, Goudreau JL, Lookingland KJ.

Brain Res. 2015 Oct 5;1622:240-51. doi: 10.1016/j.brainres.2015.06.030. Epub 2015 Jul 2.

20.

Integrating the Illness Beliefs Model in clinical practice: a Family Systems Nursing knowledge utilization model.

Duhamel F, Dupuis F, Turcotte A, Martinez AM, Goudreau J.

J Fam Nurs. 2015 May;21(2):322-48. doi: 10.1177/1074840715579404. Epub 2015 Apr 2.

PMID:
25838467
21.

Reforming primary healthcare: from public policy to organizational change.

Gilbert F, Denis JL, Lamothe L, Beaulieu MD, D'amour D, Goudreau J.

J Health Organ Manag. 2015;29(1):92-110. doi: 10.1108/JHOM-12-2012-0237.

PMID:
25735555
22.

Methylmercury impairs canonical dopamine metabolism in rat undifferentiated pheochromocytoma (PC12) cells by indirect inhibition of aldehyde dehydrogenase.

Tiernan CT, Edwin EA, Hawong HY, Ríos-Cabanillas M, Goudreau JL, Atchison WD, Lookingland KJ.

Toxicol Sci. 2015 Apr;144(2):347-56. doi: 10.1093/toxsci/kfv001. Epub 2015 Jan 19.

23.

Parkinson's disease severity and use of dopaminergic medications.

Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL; NINDS NET-PD Investigators.

Parkinsonism Relat Disord. 2015 Mar;21(3):297-9. doi: 10.1016/j.parkreldis.2014.10.016. Epub 2014 Dec 15.

24.

The role of parkin in the differential susceptibility of tuberoinfundibular and nigrostriatal dopamine neurons to acute toxicant exposure.

Benskey MJ, Manfredsson FP, Lookingland KJ, Goudreau JL.

Neurotoxicology. 2015 Jan;46:1-11. doi: 10.1016/j.neuro.2014.11.004. Epub 2014 Nov 20.

25.

GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.

Credle JJ, George JL, Wills J, Duka V, Shah K, Lee YC, Rodriguez O, Simkins T, Winter M, Moechars D, Steckler T, Goudreau J, Finkelstein DI, Sidhu A.

Cell Death Differ. 2015 May;22(5):838-51. doi: 10.1038/cdd.2014.179. Epub 2014 Nov 14.

26.

[A socioconstructivist and humanistic approach to continuing education nurses caring for people with complex needs].

Bélanger L, Goudreau J, Ducharme F.

Rech Soins Infirm. 2014 Oct 1;118(3):17-25. doi: 10.3917/rsi.118.0017. French.

PMID:
29383917
27.

[Analysis of barriers to nursing intervention for families in mental health units, in light of Collerette's change model].

Daneau S, Goudreau J, Sarrazin C.

Rech Soins Infirm. 2014 Jun;(117):21-32. Review. French.

PMID:
25080622
28.

Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.

Simkins T, Crawford RB, Goudreau JL, Lookingland KJ, Kaplan BL.

J Neuroimmune Pharmacol. 2014 Sep;9(4):544-57. doi: 10.1007/s11481-014-9549-x. Epub 2014 May 29.

PMID:
24870806
29.

[An evolutionist analysis of competence].

Charette M, Goudreau J, Alderson M.

Rech Soins Infirm. 2014 Mar;(116):28-39. Review. French.

PMID:
24830221
30.

Providing high-quality care in primary care settings: how to make trade-offs.

Beaulieu MD, Geneau R, Del Grande C, Denis JL, Hudon E, Haggerty JL, Bonin L, Duplain R, Goudreau J, Hogg W.

Can Fam Physician. 2014 May;60(5):e281-9.

31.

Scientific rigour and innovations in participatory action research investigating workplace learning in continuing interprofessional education.

Langlois S, Goudreau J, Lalonde L.

J Interprof Care. 2014 May;28(3):226-31. doi: 10.3109/13561820.2014.885003. Epub 2014 Feb 21.

PMID:
24559150
32.

[Supporting preceptor skills development with a forum discussion].

Bonnier L, Goudreau J, Déry J.

Rech Soins Infirm. 2013 Dec;(115):124-31. French.

PMID:
24490459
33.

Development of an interprofessional program for cardiovascular prevention in primary care: A participatory research approach.

Lalonde L, Goudreau J, Hudon É, Lussier MT, Bareil C, Duhamel F, Lévesque L, Turcotte A, Lalonde G; Group for TRANSIT to Best Practices in Cardiovascular Disease Prevention in Primary Care.

SAGE Open Med. 2014 Feb 17;2:2050312114522788. doi: 10.1177/2050312114522788. eCollection 2014.

34.

Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.

Parkinson Study Group SURE-PD Investigators, Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, Ahmed A, Russell DS, Cotto C, Goudreau JL, Russell D, Parashos SA, Ede P, Saint-Hilaire MH, Thomas CA, James R, Stacy MA, Johnson J, Gauger L, Antonelle de Marcaida J, Thurlow S, Isaacson SH, Carvajal L, Rao J, Cook M, Hope-Porche C, McClurg L, Grasso DL, Logan R, Orme C, Ross T, Brocht AF, Constantinescu R, Sharma S, Venuto C, Weber J, Eaton K.

JAMA Neurol. 2014 Feb;71(2):141-50. doi: 10.1001/jamaneurol.2013.5528.

35.

[The development of clinical reasoning skills and leadership: personal factors and organizational factors].

Larue C, Dubois S, Girard F, Goudreau J, Dumont K.

Rech Soins Infirm. 2013 Mar;(112):76-87. French.

PMID:
23671988
36.

Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

Benskey M, Lee KY, Parikh K, Lookingland KJ, Goudreau JL.

Neurotoxicology. 2013 Jul;37:144-53. doi: 10.1016/j.neuro.2013.04.002. Epub 2013 May 1.

37.

The role of de novo catecholamine synthesis in mediating methylmercury-induced vesicular dopamine release from rat pheochromocytoma (PC12) cells.

Tiernan CT, Edwin EA, Goudreau JL, Atchison WD, Lookingland KJ.

Toxicol Sci. 2013 May;133(1):125-32. doi: 10.1093/toxsci/kft025. Epub 2013 Feb 19.

38.

Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.

Hsu SC, Sears RL, Lemos RR, Quintáns B, Huang A, Spiteri E, Nevarez L, Mamah C, Zatz M, Pierce KD, Fullerton JM, Adair JC, Berner JE, Bower M, Brodaty H, Carmona O, Dobricić V, Fogel BL, García-Estevez D, Goldman J, Goudreau JL, Hopfer S, Janković M, Jaumà S, Jen JC, Kirdlarp S, Klepper J, Kostić V, Lang AE, Linglart A, Maisenbacher MK, Manyam BV, Mazzoni P, Miedzybrodzka Z, Mitarnun W, Mitchell PB, Mueller J, Novaković I, Paucar M, Paulson H, Simpson SA, Svenningsson P, Tuite P, Vitek J, Wetchaphanphesat S, Williams C, Yang M, Schofield PR, de Oliveira JR, Sobrido MJ, Geschwind DH, Coppola G.

Neurogenetics. 2013 Feb;14(1):11-22. doi: 10.1007/s10048-012-0349-2. Epub 2013 Jan 20.

39.

A call for transparent reporting to optimize the predictive value of preclinical research.

Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD.

Nature. 2012 Oct 11;490(7419):187-91. doi: 10.1038/nature11556.

40.

Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.

Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL.

J Neuroimmune Pharmacol. 2012 Sep;7(3):533-8. doi: 10.1007/s11481-012-9375-y. Epub 2012 May 27.

41.

Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.

Lee KY, Bae ON, Serfozo K, Hejabian S, Moussa A, Reeves M, Rumbeiha W, Fitzgerald SD, Stein G, Baek SH, Goudreau J, Kassab M, Majid A.

Stroke. 2012 Jun;43(6):1632-8. doi: 10.1161/STROKEAHA.111.639427. Epub 2012 Apr 17.

42.

Priorities for action to improve cardiovascular preventive care of patients with multimorbid conditions in primary care--a participatory action research project.

Lalonde L, Goudreau J, Hudon É, Lussier MT, Duhamel F, Bélanger D, Lévesque L, Martin É; Group for TRANSIT to Best Practices in Cardiovascular Disease Prevention in Primary Care.

Fam Pract. 2012 Dec;29(6):733-41. doi: 10.1093/fampra/cms021. Epub 2012 Feb 29.

PMID:
22379187
43.

Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

Benskey M, Behrouz B, Sunryd J, Pappas SS, Baek SH, Huebner M, Lookingland KJ, Goudreau JL.

Neurotoxicology. 2012 Jun;33(3):321-31. doi: 10.1016/j.neuro.2012.02.001. Epub 2012 Feb 9. Erratum in: Neurotoxicology. 2012 Jun;33(3):406.

44.

Healthcare professionals' adoption and use of a clinical information system (CIS) in primary care: insights from the Da Vinci study.

Vedel I, Lapointe L, Lussier MT, Richard C, Goudreau J, Lalonde L, Turcotte A.

Int J Med Inform. 2012 Feb;81(2):73-87. doi: 10.1016/j.ijmedinf.2011.11.002. Epub 2011 Dec 20.

PMID:
22192460
45.

Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation.

Ravizza SM, Goudreau J, Delgado MR, Ruiz S.

Cogn Affect Behav Neurosci. 2012 Mar;12(1):193-206. doi: 10.3758/s13415-011-0066-6.

PMID:
22006555
46.

From student to emergency nurse: a qualitative study of an educational support seminar.

Turner N, Goudreau J.

J Nurses Staff Dev. 2011 Sep-Oct;27(5):210-5. doi: 10.1097/NND.0b013e31822e0655.

PMID:
21946789
47.

Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: pharmacological evidence of activation by morphine.

Pappas SS, Kennedy T, Goudreau JL, Lookingland KJ.

Neuropharmacology. 2011 Sep;61(4):614-21. doi: 10.1016/j.neuropharm.2011.05.002. Epub 2011 May 13.

48.

Use of a script concordance test to assess development of clinical reasoning in nursing students.

Deschênes MF, Charlin B, Gagnon R, Goudreau J.

J Nurs Educ. 2011 Jul;50(7):381-7. doi: 10.3928/01484834-20110331-03. Epub 2011 Mar 31.

PMID:
21449528
49.

Physician-pharmacist collaborative care in dyslipidemia management: the perception of clinicians and patients.

Lalonde L, Hudon E, Goudreau J, Bélanger D, Villeneuve J, Perreault S, Blais L, Lamarre D.

Res Social Adm Pharm. 2011 Sep;7(3):233-45. doi: 10.1016/j.sapharm.2010.05.003. Epub 2010 Jul 23.

PMID:
21272548
50.

Liquid chromatographic-electrospray mass spectrometric determination of 1-methyl-4-phenylpyridine (MPP+) in discrete regions of murine brain.

Lehner A, Johnson M, Simkins T, Janis K, Lookingland K, Goudreau J, Rumbeiha W.

Toxicol Mech Methods. 2011 Mar;21(3):171-82. doi: 10.3109/15376516.2010.538753. Epub 2010 Dec 13.

Supplemental Content

Loading ...
Support Center